MARIA LUISA
FERRANDIZ MANGLANO
CATEDRÀTIC/A D'UNIVERSITAT
MARIA CARMEN
TERENCIO SILVESTRE
CATEDRÀTIC/A D'UNIVERSITAT
Publications by the researcher in collaboration with MARIA CARMEN TERENCIO SILVESTRE (27)
2024
-
Adenosine A2B receptor agonist improves epidermal barrier integrity in a murine model of epidermal hyperplasia
Biomedicine and Pharmacotherapy, Vol. 173
-
Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression
International Journal of Molecular Sciences, Vol. 25, Núm. 5
2022
-
Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1
International journal of molecular sciences, Vol. 23, Núm. 15
2019
-
Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis
International Journal of Molecular Sciences, Vol. 20, Núm. 16
2016
-
Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats
Biomedicine and Pharmacotherapy, Vol. 79, pp. 120-128
2015
-
Effects of BIS076 in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats
BMC Musculoskeletal Disorders, Vol. 16, Núm. 1
2014
-
Influence of age on osteoarthritis progression after anterior cruciate ligament transection in rats
Experimental Gerontology, Vol. 55, pp. 44-48
2012
-
Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis
Experimental Gerontology, Vol. 47, Núm. 5, pp. 406-409
2010
-
Elaboración de videos didácticos como alternativa a los ensayos in vivo en las prácticas de farmacología
Ars pharmaceutica, Vol. 51, Núm. 2, pp. 162-168
-
Farmacinema: recurso docente en el aprendizaje de Farmacología y Farmacia Clínica
Ars pharmaceutica, Vol. 51, Núm. 2, pp. 169-176
2007
-
Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor
Life Sciences, Vol. 80, Núm. 23, pp. 2108-2117
2006
-
Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase
Life Sciences, Vol. 78, Núm. 25, pp. 2911-2918
2005
-
Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis
Arthritis and Rheumatism, Vol. 52, Núm. 10, pp. 3230-3238
2004
-
Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells
British Journal of Pharmacology, Vol. 142, Núm. 7, pp. 1191-1199
2001
-
Inhibition of 5-lipoxygenase activity by the natural anti-inflammatory compound aethiopinone
Inflammation Research, Vol. 50, Núm. 2, pp. 96-101
2000
-
Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 361, Núm. 1, pp. 98-106
1999
-
Inhibition of human sPLA2 and 5-lipoxygenase activities by two neo- clerodane diterpenoids
Life Sciences, Vol. 64, Núm. 19
1998
-
A new cacospongionolide inhibitor of human secretory phospholipase A2 from the tyrrhenian sponge Fasciospongia cavernosa and absolute configuration of cacospongionolides
Journal of Natural Products, Vol. 61, Núm. 7, pp. 931-935
-
Anti-inflammatory activity in mice of extracts from Mediterranean marine invertebrates
Life Sciences, Vol. 62, Núm. 9
-
Suppression of leukotriene B4 and tumour necrosis factor α release in acute inflammatory responses by novel prenylated hydroquinone derivatives
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 357, Núm. 5, pp. 565-572